
|Articles|February 6, 2023
POLL: Are You Attending South Beach Symposium?
Author(s)Dermatology Times Staff
Listen
0:00 / 0:00
Key Takeaways
- Personalized treatment strategies have advanced the management of lung cancer brain metastases, improving patient outcomes.
- Targeted therapies and immunotherapies offer new hope, with molecular profiling and advanced imaging enabling precise treatment planning.
Click here to answer this week's poll.
Advertisement
Are You Attending South Beach Symposium?
If you can't attend South Beach Symposium,
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Clascoterone 5% Delivers Strong Phase 3 Hair-Growth Results
2
Derm Dispatch: What 'Free to Be Me' Means to Tori Spelling and Stella McDermott
3
Reviewing Type 2 Inflammation Through a Different Lens
4
Alpha-9 Begins First-in-Human Trial of MC1R-Targeted Radiotherapeutic
5


















